Combination Therapy With GEN0101 and Pembrolizmub in Advanced Melanoma Patients PIb/PII
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Advanced Melanoma
Related studies linked through entity extraction aliases.
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma.
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004)
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression
- Status
- TERMINATED
- Phase
- PHASE2
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
- Status
- COMPLETED
- Phase
- N/A
APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Immunologic Determinants of Response to Pembrolizumab (MK-3475) in Advanced Melanoma (MK-3475-161/KEYNOTE-161)
- Status
- TERMINATED
- Phase
- PHASE2
A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma
- Status
- RECRUITING
- Phase
- PHASE1
Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tolerability and Pharmacokinetics of Toripalimab in Combination With Axitinib in Patients With Kidney Cancer and Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Patients With Locally Advanced or Metastatic Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Efficacy of DCB-BO1301 in Advanced Melanoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 in Patients With Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Anti-PD-1 (Pembrolizumab) Therapy in Metastatic Melanoma (ADAPTeM)
- Status
- WITHDRAWN
- Phase
- PHASE2
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan
- Status
- COMPLETED
- Phase
- N/A